Philip Krause
Fortuna: 389 396 $ al 30/06/2026
Fortuna: 389 396 $ al 30/06/2026
Philip R.
Krause currently works at Mesoblast Ltd., as Independent Non-Executive Director from 2022.
Dr. Krause also formerly worked at US Food & Drug Administration, as Deputy Director.
Dr. Krause received his Masters Business Admin degree from Florida State University, undergraduate degree and graduate degree from the University of Illinois, and doctorate degree in 1984 from Yale School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MESOBLAST LIMITED 0,02 % | 18/03/2026 | 287.500 ( 0,02 % ) | 389 396 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MESOBLAST LIMITED | Director/Miembro de la Junta | 24/03/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Florida State University
Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.